Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Coming Soon To Amazon: Neosante’s Colic Drops

By Neosante Health Solutions | April 5, 2018

Neosante Health Solutions’ top-selling Delictase Oral Drops, a lactase enzyme supplement used to battle baby colic, will soon be available to a much larger audience on Amazon.com, the world’s largest online retailer.

Delictase Oral Drops prevent excessive crying and discomfort for babies suffering from colic, a common issue most likely caused by gastrointestinal discomfort, including intestinal cramping. Colic affects up to 40 percent of children, typically occurring when a child is between six weeks and six months old, rarely lasting more than a year.

“Getting Delictase on the world’s biggest retailer will help prevent sleepless nights for countless babies and their parents,” Neosante CEO João Santos said. “We stand by being the best colic remedy, and know Amazon will help people around the world find us as we continue to branch out. Parents need to know a product exists that treats their baby’s crying and improves their overall health by treating the cause, not the symptoms.

“Delictase provides just enough lactase to infants to treat colic. It helps babies who may have hypolactasia, but is not intended for severe lactose intolerance. Lactase is used to digest lactose, preventing fermentation in the body that leads to tummy pains. Lactose also makes the baby’s gut more acidic, which causes diarrhea and really foul diapers.”

Delictase Oral Drops come in a 15-milliliter solution, prepackaged in a dropper, and should be added to breast milk or baby formula. Neosante is a well-known company overseas, having sold more than two million vials of Delictase Oral Drops in 2017 alone, predominately to health-conscious parents coping with baby colic.

Neosante Health Solutions is a privately owned Portuguese pharmaceutical company established in 2007 that produces food supplements, medical devices and cosmetics. Neosante currently distributes products to 20 countries on three continents, and is bringing its most popular item, Delictase Oral Drops, to parents in the U.S.

(Source: Neosante Health Solutions)


Filed Under: Drug Discovery

 

Related Articles Read More >

EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE